Voltage-Gated Sodium Channel Ligands
Journal of Medicinal Chemistry, 2004, Vol. 47, No. 26 6527
(28) Waxman, S. G.; Cummins, T. R.; Dib-hajj, S. D.; Black, J. A.
Voltage-gated Sodium Channels and the Molecular Pathogenesis
of Pain: a Review. J. Rehabil. Res. Dev. 2000, 37 (5), 517-28.
(29) Deffois, A.; Fage, D.; Carter, C. Inhibition of Synaptosomal
Veratridine-Induced Sodium Influx by Antidepressants and
Neuroleptics Used in Chronic Pain. Neurosci. Lett. 1996, 220
(2), 117-20.
(30) Li, H.-L.; Galue, A.; Meadows, L.; Ragsdale, D. S. A Molecular
Basis for the Different Local Anesthetic Affinities of Resting
Versus Open and Inactivated States of the Sodium Channel. Mol.
Pharmacol. 1999, 55 (1), 134-41.
(31) Ragsdale, D. S.; McPhee, J. C.; Scheuer, T.; Catterall, W. A.
Common Molecular Determinants of Local Anesthetic, Antiar-
rhythmic and Anticonvulsant Block of Voltage-Gated Na+ Chan-
nels. Proc. Natl. Acad. Sci. U.S.A. 1998, 93, 9270-5.
(32) Catterall, W. A. Common Modes of Drug Action on Na+ Chan-
nels: Local Anesthetics, Antiarrhythmics and Anticonvulsants.
Trends Pharmacol. Sci. 1987, 8, 57-65.
(33) Ragsdale, D. S.; McPhee, J. C.; Scheuer, T.; Catterall, W. A.
Molecular Determinants of State-Dependents Block of Na+
Channels by Local Anesthetics. Science 1994, 265, 1724-8.
(34) Qu, Y.; Rogers, J.; Tanade, T.; Scheuer, T.; Catterall, W. A.
Molecular Determinant of Drug Access to the Receptor Site for
Antiarrhythmic Drugs in Cardiac Na+ Channel. Proc. Natl.
Acad. Sci. U.S.A. 1995, 92 (5), 11839-43.
(35) De Leon, L.; Ragsdale, D. S. State-dependent Access to the
Batrachotoxin Receptor on the Sodium Channel. NeuroReport
2003, 14 (10), 1353-6.
(36) Courtney, K. R. Structure-Activity Relations for Frequency
Dependent Sodium Channel Block in Nerve by Local Anesthet-
ics. J. Pharmacol. Exp. Ther. 1980, 213 (1), 114-9.
(37) Liu, G.; Yarov-Yarovoy, V.; Nobbs, M.; Clare, J. J.; Scheuer, T.;
Catterall, W. A. Differential Interactions of Lamotrigine and
Related Drugs with Transmembrane Segment IVS6 of Voltage-
gated Sodium Channels. Neuropharmacology 2003, 44, 413-22.
(38) (a) Khodorov, B. I. Sodium Inactivation and Drug-Induced
Immobilization of the Gating Charge in Nerve Membrane. Prog.
Biophys. Mol. Biol. 1981, 37, 49-89. (b) Unverferth, K.; Engel,
J.; Ho¨fgen, N.; Rostock, A.; Gu¨nther, R.; Lankau, H.-J.; Menzer,
M.; Rolfs, A.; Liebscher, J.; Mu¨ller, B.; Hofmann, H.-J. Synthesis,
Anticonvulsant Activity, and Structure-Activity Relationships
of Sodium Channel Blocking 3-Aminopyrroles. J. Med. Chem.
1998, 41, 63-73.
References
(1) Urenjak, J.; Obrenovitch, T. P. Pharmacologicol Modulation of
Voltage-Gated Na+ Channels: A Rational and Effective Strategy
Against Ischemic Brain Damage. Pharmacol. Rev. 1996, 48, 21-
67.
(2) Hille, B. Ionic Channels of Excitable Membranes; Sinauer
Associates: Sunderland, MA, 1991.
(3) Catteral, W. A. Molecular Properties of Sodium and Calcium
Channels. J. Bioenerg. Biomembr. 1996, 28 (3), 219-30.
(4) Catteral, W. A. Structure and Function of Voltage-Sensitive Ion
Channels. Annu. Rev. Biochem. 1995, 64, 493-531.
(5) Catteral, W. A. Structure and Function of Voltage-Sensitive Ion
Channels. Science 1988, 242, 50-61.
(6) Catterall, W. A. Molecular Mechanisms of Gating and Drug
Block of Sodium Channels. Novartis Found. Symp. 2002, 241,
206-18.
(7) Wood, J. N.; Baker, M. Voltage-gated Sodium Channels. Curr.
Opin. Pharmacol. 2001, 1 (1), 17-21.
(8) Yu, F. H.; Catterall, W. A. Overview of the Voltage-gated Sodium
Channel Family. Genome Biol. 2003, 4 (3), 207.
(9) Taylor, C. P.; Narasimhan, L. S. Sodium Channels and Therapy
of Central Nerve System Diseases. Adv. Pharmacol. 1997, 39,
447-98.
(10) Yao, C.; Williams, A. J.; Lu, X. C.; Price, R. A.; Cunningham, B.
S.; Berti, R.; Tortella, F. C.; Dave, J. R. The Sodium Channel
Blocker RS 100642 Reverses Down-regulation of the Sodium
Channel Alpha-subunit Na(v) 1.1 Expression Caused by Tran-
sient Ischemic Brain Injury in Rats. Neurotoxic. Res. 2003, 5
(4), 245-54.
(11) Lingamaneni, R.; Hemmings, H. C., Jr. Differential Interaction
of Anaesthetics and Antiepileptic Drugs with Neuronal Na+
Channels, Ca2+ Channels, and GABA (A) Receptors. Br. J.
Anaesth. 2003, 9 (2), 199-211.
(12) Kohling, R. Voltage-gated Sodium Channels in Epilepsy. Epi-
lepsia 2002, 43 (11), 1278-95.
(13) Vamecq, J.; Lambert, D.; Poupaart, J. H.; Masereel, B.; Stables,
J. P. Anticonvulsant Activity and Interactions with Neuronal
Voltage-dependent Sodium Channel of Analogues of Ameltolide.
J. Med. Chem. 1998, 41 (18), 3307-13.
(14) Cosford, N. D.; Meinke, P. T.; Stauderman, K. A.; Hess, S. D.
Recent Advances in the Modulation of Voltage-gated Ion Chan-
nels for the Treatment of Epilepsy. Curr. Drug Targets: CNS
Neurol. Disord. 2002, 1 (1), 81-104.
(15) Ragsdale, D. S.; Avoli, M. Sodium Channels as Molecular Targets
for Antiepileptic Drugs. Brain Res. Rev. 1998, 26, 16-28.
(16) Campell, T. J.; Williams, K. M. Therapeutic Drug Monitoring:
Antiarrhythmic Drugs. Br. J. Clin. Pharmacol. 1998, 46 (4),
307-49.
(17) Sheldon, R. S.; Duff, H. J.; Thakore, E.; Hill, R. J. Class I
Antiarrhythmic Drugs: Allosteric Inhibitors of [3H] Batra-
chotoxinin Binding to Rat Cardiac Sodium Channels. J. Phar-
macol. Exp. Ther. 1994, 268 (1), 187-94.
(39) Roufos, I.; Hays, S. J.; Dooley, D. J.; Schwarz, R. D.; Campbell,
G. W.; Probert, A. W. Synthesis and Pharmacological Evaluation
of Phenylacetamides as Sodium-Channel Blockers. J. Med.
Chem. 1994, 37, 268-74.
(40) Roufos, I.; Hays, S. J.; Dooley, D. J.; Schwarz, R. D. A Structure-
Activity Relationship Study of Novel Phenylacetamides Which
Are Sodium Channel Blockers. J. Med. Chem. 1996, 39, 1514-
20.
(41) De Luca, A.; Talon, S.; De Bellis, M.; Desaphy, J.-F.; Lentini,
G.; Corbo, F.; Scilimati, A.; Franchini, C.; Tortorella, V. Optimal
Requirements for High Affinity and Use-Dependent Block of
Skeletal Muscle Sodium Channel by N-Benzyl Analogs of
Tocainide-Like Compounds. Mol. Pharmacol. 2003, 64, 932-45
and references therein.
(42) Cestele, S.; Catterall, W. A. Molecular Mechanisms of Neurotoxin
Action on Voltage-Gated Sodium Channels. Biochimie 2000, 82,
883-92.
(43) Grauert, M.; Bechtel, W. D.; Weiser, T.; Werner, S.; Nar, H.;
Carter, A. J. Synthesis and Structure-Activity Relationships
of 6,7-Benzomorphan Derivatives as Use-Dependent Sodium
Channel Blockers for the Treatment of Stroke. J. Med. Chem.
2002, 45, 3755-64.
(44) Leong, D.; Bloomquist, J. R.; Bempong, J.; Dybas, J. A.; Kinne,
L. P.; Lyga, J. W.; Marek, F. L.; Nicholson, R. A. Insecticidal
Arylalkylbenzhydrolpiperidines: Novel Inhibitors of Voltage-
Sensitive Sodium and Calcium Channels in Mammalian Brain.
Pest Manage. Sci. 2001, 57, 889-95.
(45) Nicholson, R. A.; Liao, C.; Zheng, J.; David, L. S.; Coyne, L.;
Errington, A. C.; Singh, G.; Lees, G. Sodium Channel Inhibition
by Anandamide and Synthetic Cannabimimetics in Brain. Brain
Res. 2003, 978, 194-204.
(46) Anger, T.; Madge, D. J.; Mulla, M.; Riddall, D. Medicinal
Chemistry of Neuronal Voltage-Gated Sodium Channels. J. Med.
Chem. 2001, 44, 115-37.
(47) Meza-Toledo, S. E.; Zenteno-Garcia, M. T.; Juarez-Carvajal, E.;
Martinez-Munoz, D.; Carvajal-Sandoval, G. A. New Homologous
Series of Anticonvulsants: Phenyl Alcohol Amides. Arzneim-
Forsch. 1990, 40 (11), 1289-90.
(48) Brown, M. L.; Zha, C. C.; Van Dyke, C. C.; Brown, G. B.;
Brouillette, W. J. Comparative Molecular Field Analysis of
Hydantoin Binding to the Neuronal Voltage-Dependent Sodium
Channel. J. Med. Chem. 1999, 42, 1537-45.
(18) Sheldon, R. S.; Cannon, N. J.; Duff, H. J. A Receptor for Type I
Antiarrhythmic Drugs Associated with Rat Cardiac Channels.
Circ. Res. 1987, 61 (4), 492-7.
(19) Catterall W. A. Inhibition of Voltage-sensitive Sodium Channels
in Neuroblastoma Cells by Antiarrhythmic Drugs. Mol. Phar-
macol. 1981, 20, 356-62.
(20) McNeal, E. T.; Lawandowski, G. A.; Daly, J. W.; Creveling, C.
R. [3H]Batrachotoxinin A 20-R-Benzoate Binding to Voltage-
Sensitive Sodium Channels: A Rapid and Quantitative Assay
for Local Anesthetic Activity in a Variety of Drugs. J. Med.
Chem. 1985, 28, 381-8.
(21) Creveling, C. R.; McNeal, E. T.; Daly, J. W.; Brown, G. B.
Batrachotoxin-Induced Depolarization and [3H]Batrachotoxinin-
A 20R-Benzoate Binding in a Vesicular Preparation from Guinea
Pig Cerebral Cortex. Inhibition by Local Anesthetics. Mol.
Pharmacol. 1983, 23, 350-8.
(22) Klamt, J. G. Effects of Intrathecally Administrated Lamotrigine,
a Glutamate Release Inhibitor, on Short- and Long-Term Models
of Hyperalgesia in Rats. Anesthesiology 1998, 88 (2), 487-94.
(23) di Vadi, P. P.; Hamann, W. The Use of Lamotrigine in Neuro-
pathic Pain. Anaesthesia 1998, 53 (80), 808-9.
(24) Deffois, A.; Fage, D.; Carter, C. Inhibition of Synaptosomal
Veratridine-induced Sodium Influx by Antidepressants and
Neuroleptics Used in Chronic Pain. Neurosci. Lett. 1996, 220,
117-20.
(25) Waxman, S. G.; Cummins, T. R.; Dib-Hall, S.; Fjell, J.; Black, J.
A. Sodium Channels, Excitability of Primary Sensory Neurons,
and the Molecular Basis of Pain. Muscle Nerve 1999, 22, 1177-
87.
(26) Melena, J.; Chidlow, G.; Osborne, N. N. Blockade of Voltage-
sensitive Na+ Channels by the 5-HT (1A) Receptor Agonist
8-OH-DPAT: Possible Significance for Neuroprotection. Eur. J.
Pharmacol. 2000, 406 (3), 319-24.
(27) Waxman, S. G. Acquired Channelopathies in Nerve Injury and
MS. Neurology 2001, 236 (1), 5-16.